Loading
Latest filing published 20 Nov 2023 for Navidea Biopharmaceuticals, INC.. Read the official filing
No signal scores available.
Dana J. Moss is a declared insider of Navidea Biopharmaceuticals, Inc., with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated from 11 July 2023 to 16 November 2023.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 20 November 2023, the filings show a share grant in Navidea Biopharmaceuticals, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations